9,10-dimethyl-1,2-benzanthracene and cetrorelix

9,10-dimethyl-1,2-benzanthracene has been researched along with cetrorelix in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Comaru-Schally, AM; Engel, J; Harleman, JH; Hilgard, P; Reissmann, T; Schally, AV	1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and cetrorelix

Article	Year
Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormone. Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:1 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Gonadotropin-Releasing Hormone; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Triptorelin Pamoate	1992

Article

Year

Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormone.

Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:1

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Gonadotropin-Releasing Hormone; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Triptorelin Pamoate

1992